Mind Medicine (MNMD)
NASDAQ:MNMD

Mind Medicine (MNMD) Stock Forecast & Price Target

335 Followers
See the Price Targets and Ratings of:

MNMD Analyst Ratings

Strong Buy
5Ratings
5 Buy
0 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Mind
Medicine
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MNMD Stock 12 Months Forecast

Average Price Target

$31.46
▲(1076.10% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Mind Medicine in the last 3 months. The average price target is $31.46 with a high forecast of $74.67 and a low forecast of $4.98. The average price target represents a 1076.10% change from the last price of $2.68.
Highest Price Target$74.67Average Price Target$31.46Lowest Price Target$4.98
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Cantor Fitzgerald
$45.00
Buy
1582.24%
Upside
Initiated
MindMed initiated with an Overweight at Cantor FitzgeraldMindMed initiated with an Overweight at Cantor Fitzgerald
Roth Capital
$105.00
Buy
3825.23%
Upside
Initiated
MindMed initiated with a Buy at Roth CapitalMindMed initiated with a Buy at Roth Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

MNMD Financial Forecast

MNMD Earnings Forecast
Next quarter’s earnings estimate for MNMD is -$0.48 with a range of -$0.60 to -$0.43. The previous quarter’s EPS was -$0.56. MNMD beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.49% of the time in the same period. In the last calendar year MNMD has Outperformed its overall industry.
Next quarter’s earnings estimate for MNMD is -$0.48 with a range of -$0.60 to -$0.43. The previous quarter’s EPS was -$0.56. MNMD beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.49% of the time in the same period. In the last calendar year MNMD has Outperformed its overall industry.
No data currently available
MNMD Sales Forecast
Next quarter’s sales forecast for MNMD is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. MNMD beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 42.83% of the time in the same period. In the last calendar year MNMD has Underperformed its overall industry.
Next quarter’s sales forecast for MNMD is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. MNMD beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 42.83% of the time in the same period. In the last calendar year MNMD has Underperformed its overall industry.
MNMD Analyst Recommendation Trends
In the current month, MNMD has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MNMD average analyst price target in the past 3 months is $31.46
In the current month, MNMD has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MNMD average analyst price target in the past 3 months is $31.46

MNMD Stock Forecast FAQ

What is MNMD’s average 12-month price target, according to analysts?
Based on analyst ratings, Mind Medicine’s 12-month average price target is $31.46.
    What is MNMD’s upside potential, based on the analysts’ average price target?
    Mind Medicine has 1076.10% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MNMD a Buy, Sell or Hold?
          Mind Medicine has a conensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Mind Medicine’s price target?
            The average price target for Mind Medicine is $31.46. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $74.67 ,the lowest forecast is $4.98. The average price target represents 1076.10% Increase from the current price of $2.675.
              What do analysts say about Mind Medicine?
              Mind Medicine’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis